Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-07-09
1999-12-07
Lee, Howard C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514384, 544359, 544367, A61K 31495, A61K 3150, C07D40314
Patent
active
059984139
ABSTRACT:
Anti-infective compositions for the treatment of a human in need of therapy for a systemic or topical fungal infection which comprise a pharmaceutically acceptable carrier and a therapeutically effective amount of (2R,4S) itraconazole or a pharmaceutically acceptable salt thereof, substantially free of its (2S,4R) stereoisomer.
REFERENCES:
patent: 4267179 (1981-05-01), Heeres et al.
patent: 4490530 (1984-12-01), Heeres et al.
patent: 4983583 (1991-01-01), Bodor
patent: 5002935 (1991-03-01), Bodor
patent: 5017566 (1991-05-01), Bodor
patent: 5024998 (1991-06-01), Bodor
patent: 5214046 (1993-05-01), Guerry et al.
patent: 5474997 (1995-12-01), Gray et al.
Nerurkar et al. J. Clin. Pharm., vol. 32(10):935-943, (1992). Abstract only.
Hardin, et al., "Pharmacokinetics of Itraconazole following Oral Administration to Normal Volunteers", Antimicrobial Agents and Chemotherapy, 32, No. 9, 1988, 1310-1313.
J. Heeres, et al., "Antimycotic Azoles. 7. Synthesis and Antifungal Properties of a Series of Novel Triazol-3-ones", J. Med. Chem., 27, No. 7, 1984, 894-900.
Hostetler, et al., "Effect of cyclodextrin on the pharmacology of antifungal oral azoles", Antimicrobial Agents and Chemother., 36, (2), 1992, 477-480.
Stinson, "Wave of new enantiomer products set to flood the market as chemists develop chiral technology for large-scale production processes", C&EN, 71(39), Sep. 27, pp. 38-63.
Stinson, "New single-isomer products on the chiral drug market create demand for enantiomeric intermediates and enantioselective technologies", C&EN, 72(38), Sep. 19, 1994, pp. 38-72.
J. Van Cutsem, et al., "Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals", Antimicrobial Agents and Chemo., 33, No. 12, 1989, 2063-2068.
J. Van Cutsem, et al., "Antimycotic Azoles. 7. Synthesis and Antifungal Properties of a Series of Novel Triazol-3-ones", J. Med. Chem., 27, No. 7, 1984, 894-900.
J. Van Cutsem, et al., "In vitro Antifungal Spectrum of Itraconazole and Treatment of Systemic Mycoses with Old and New Antimycotic Agents", J. Chemother., 38, Supp. 1, 1992, 3-11.
Heeres Jan
Mesens Jean Louis
Peeters Jozef
Janssen Pharmaceutica N.V.
Lee Howard C.
LandOfFree
Itraconazole and stereoisomers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Itraconazole and stereoisomers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Itraconazole and stereoisomers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824066